Biolipox AB

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, chronic obstructive pulmonary disease (COPD), rhinitis, pain and arthritis. The discoveries that form the basis of our understanding of the role of arachidonic acid in inflammatory processes were rewarded with the Nobel Prize in 1982. One of the prize winners, Professor Bengt Samuelsson, is currently a member of the Board of Biolipox.

Arachidonic acid is an endogenous substance that through transformation to prostaglandins and leukotrienes regulates a number of inflammatory processes in the body. Biolipox's discovery of a new family - eoxins - formed from the transformation of arachidonic acid, marked the beginning of the company's research on an entirely new class of anti-inflammatory drugs.

Biolipox was founded in June, 2000 and has since then evolved into a research-intensive pharmaceutical company, today counting four full drug development projects in both pre-clinical and clinical phases. One of the projects is aimed at developing a new pain-relieving medication, with a completely new mechanism of action, for the treatment of arthritis patients.

The market for Biolipox's priority research areas was in 2003 USD 40bn (1, 2). These are among today's fastest growing therapeutic areas

Contact Details: Berzelius väg 3, plan 5 Solna SE-171 65 Sweden Tel: 46 8 524 83 100 Fax: Email: peter.hein@biolipox.com WWW: www.biolipox.se/

Recent Publications by Biolipox AB:
Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells. Human eosinophils contain abundant amounts of 15-lipoxygenase (LO)-1. The...	7th February, 2008	Biolipox AB, Berzelius Vag 3, SE-171 65 Solna, Sweden.	Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):680-5. Epub 2008 Jan 9. DOI Direct Link

BioNews Results for Biolipox AB:
Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation	Pharma Live:  Nov 23 2009 4:22AM Matching: ab
BE Group Win 100 Million SEK Reinforcing Steel Supply Contract	Research & Development:  Nov 23 2009 3:17AM Matching: ab
Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation	PR Newswire:  Nov 23 2009 12:48AM Matching: ab
Video: Breast Cancer Walk	San Diego 6:  Nov 22 2009 7:34AM Matching: ab
Video: Kids with Cancer Walk	San Diego 6:  Nov 22 2009 7:34AM Matching: ab
Promote your company here: BioNewsCast - Press Release Distribution	→View more Biolipox AB news.

Biolipox AB Clinical Trials:
Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic Rhinitis

Biolipox AB Patents:
US Patent No.	Title
7459479	Benzylated PDE4 inhibitors
7446129	Benzylated PDE4 inhibitors

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 614 times since April 2007, the link to the organisation's website has been followed 106 times

Recent Search Terms used to find this page: Biolipox ab healthcare | biolipox | Biolipox AB | Biolipox AB | biolipox | biolipox ab | biolipox ab | biolipox ab | biolipox ab | Biolipox AB | .

Search for more companies in Solna

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Biolipox AB